• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性胰腺神经内分泌肿瘤队列中生长抑素受体1 - 5表达、[镓]镓 - DOTANOC、[氟]氟 - FDG PET/CT与临床结局的相关性

Correlation of Somatostatin Receptor 1-5 Expression, [Ga]Ga-DOTANOC, [F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms.

作者信息

Majala Susanna, Vesterinen Tiina, Seppänen Hanna, Mustonen Harri, Sundström Jari, Schalin-Jäntti Camilla, Gullichsen Risto, Schildt Jukka, Kemppainen Jukka, Arola Johanna, Kauhanen Saila

机构信息

Department of Surgery, Division of Digestive Surgery and Urology, Turku University Hospital, University of Turku, P.O. Box 52, FIN-20521 Turku, Finland.

Turku PET Centre, Turku University Hospital, P.O. Box 52, FIN-20521 Turku, Finland.

出版信息

Cancers (Basel). 2021 Dec 29;14(1):162. doi: 10.3390/cancers14010162.

DOI:10.3390/cancers14010162
PMID:35008325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8750461/
Abstract

PURPOSE

The aim of this study was to correlate immunohistochemical (IHC) tissue levels of SSTR1-5 with the receptor density generated from [Ga]Ga-DOTANOC uptake in a prospective series of NF-PNENs.

METHODS

Twenty-one patients with a total of thirty-five NF-PNEN-lesions and twenty-one histologically confirmed lymph node metastases (LN+) were included in this prospective study. Twenty patients were operated on, and one underwent endoscopic ultrasonography and core-needle biopsy. PET/CT with both [Ga]Ga-DOTANOC and [F]F-FDG was performed on all patients. All histological samples were re-classified and IHC-stained with monoclonal SSTR1-5 antibodies and Ki-67 and correlated with [Ga]Ga-DOTANOC and [F]F-FDG PET/CT.

RESULTS

Expression of SSTR1-5 was detected in 74%, 91%, 80%, 14%, and 77% of NF-PNENs. There was a concordance of SSTR2 IHC with positive/negative [Ga]Ga-DOTANOC finding (Spearman's rho 0.382, = 0.043). All [Ga]Ga-DOTANOC-avid tumors expressed SSTR2 or SSTR3 or SSTR5. Expression of SSTR5 was higher in tumors with a low Ki-67 proliferation index (PI) (-0.353, 95% CI -0.654-0.039, = 0.038). The mean Ki-67 PI for SSTR5 positive tumors was 2.44 (SD 2.56, CI 1.0-3.0) and 6.38 (SD 7.25, CI 2.25-8.75) for negative tumors.

CONCLUSION

SSTR2 was the only SSTR subtype to correlate with [Ga]Ga-DOTANOC PET/CT. Our prospective study confirms SSTR2 to be of the highest impact for SST PET/CT signal.

摘要

目的

本研究旨在在前瞻性队列的神经内分泌性胰腺非功能性肿瘤(NF-PNENs)中,将SSTR1 - 5的免疫组化(IHC)组织水平与[镓]Ga-DOTANOC摄取所产生的受体密度进行关联分析。

方法

本前瞻性研究纳入了21例患者,共有35个NF-PNEN病灶以及21个经组织学证实的淋巴结转移灶(LN+)。20例患者接受了手术,1例接受了内镜超声检查和粗针活检。所有患者均进行了[镓]Ga-DOTANOC和[氟]F-FDG的PET/CT检查。所有组织学样本均重新分类,并用单克隆SSTR1 - 5抗体、Ki-67进行IHC染色,并与[镓]Ga-DOTANOC和[氟]F-FDG PET/CT结果进行关联分析。

结果

在74%、91%、80%、14%和77%的NF-PNENs中检测到SSTR1 - 5的表达。SSTR2 IHC结果与[镓]Ga-DOTANOC阳性/阴性结果存在一致性(Spearman等级相关系数0.382,P = 0.043)。所有摄取[镓]Ga-DOTANOC的肿瘤均表达SSTR2或SSTR3或SSTR5。在Ki-67增殖指数(PI)较低的肿瘤中,SSTR5的表达较高(-0.353,95%置信区间-0.654 - 0.039,P = 0.038)。SSTR5阳性肿瘤的平均Ki-67 PI为2.44(标准差2.56,置信区间1.0 - 3.0),阴性肿瘤为6.38(标准差7.25,置信区间2.25 - 8.75)。

结论

SSTR2是唯一与[镓]Ga-DOTANOC PET/CT相关的SSTR亚型。我们的前瞻性研究证实SSTR2对SST PET/CT信号影响最大。

相似文献

1
Correlation of Somatostatin Receptor 1-5 Expression, [Ga]Ga-DOTANOC, [F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms.前瞻性胰腺神经内分泌肿瘤队列中生长抑素受体1 - 5表达、[镓]镓 - DOTANOC、[氟]氟 - FDG PET/CT与临床结局的相关性
Cancers (Basel). 2021 Dec 29;14(1):162. doi: 10.3390/cancers14010162.
2
Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.基于双示踪剂PET/CT对无功能胰腺神经内分泌肿瘤侵袭性的预测
EJNMMI Res. 2019 Dec 23;9(1):116. doi: 10.1186/s13550-019-0585-7.
3
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.肺神经内分泌肿瘤 somatostatin 受体 PET/CT 成像特征与免疫组化的相关性:一项回顾性观察研究。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4182-4193. doi: 10.1007/s00259-022-05848-z. Epub 2022 Jun 8.
4
Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at Ga-DOTANOC PET/CT imaging.在淋巴瘤中生长抑素受体的表达:Ga-DOTANOC PET/CT 成像时误诊为神经内分泌肿瘤的一个来源。
Acta Oncol. 2018 Feb;57(2):283-289. doi: 10.1080/0284186X.2017.1342864. Epub 2017 Jul 7.
5
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者中 68Ga-DOTANOC 与 68Ga-DOTATATE PET/CT 的比较。
J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7.
6
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.68Ga-DOTANOC PET/CT 与 18F-FDG PET/CT 对分化型神经内分泌肿瘤患者预后价值的比较。
Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2194-202. doi: 10.1007/s00259-014-2850-3. Epub 2014 Jul 17.
7
Prospective evaluation of (68)Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative (131)I-whole body scan: comparison with (18)F-FDG PET-CT.前瞻性评估 (68)Ga-DOTANOC PET-CT 在甲状腺球蛋白升高且 (131)I-全身扫描阴性的分化型甲状腺癌患者中的应用:与 (18)F-FDG PET-CT 的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1354-62. doi: 10.1007/s00259-014-2723-9. Epub 2014 Feb 22.
8
Ga-DOTANOC and F-FDG PET/CT in metastatic medullary thyroid carcinoma: novel correlations with tumoral biomarkers.Ga-DOTANOC 和 F-FDG PET/CT 在转移性甲状腺髓样癌中的应用:与肿瘤标志物的新关联。
Endocrine. 2019 May;64(2):322-329. doi: 10.1007/s12020-019-01846-8. Epub 2019 Jan 25.
9
Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India.镓-68 DOTANOC PET/CT成像在不明原发灶转移性神经内分泌肿瘤患者原发部位检测中的应用及其对临床决策的影响:来自印度一家三级医疗中心的经验
J Gastrointest Oncol. 2016 Jun;7(3):449-61. doi: 10.21037/jgo.2016.01.06.
10
Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy.高级别胶质瘤中的生长抑素受体2型:使用(68)Ga-DOTA肽的PET/CT、与预后标志物的相关性以及对靶向放疗的意义
EJNMMI Res. 2015 Apr 22;5:25. doi: 10.1186/s13550-015-0106-2. eCollection 2015.

引用本文的文献

1
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies.神经内分泌肿瘤体内与体外生长抑素受体表达:相关性研究的系统评价与Meta分析
Int J Mol Sci. 2025 Jul 8;26(14):6551. doi: 10.3390/ijms26146551.
2
Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia.生长抑素受体显像在甲状旁腺神经内分泌肿瘤诊断与治疗中的应用
Diagnostics (Basel). 2024 Dec 3;14(23):2718. doi: 10.3390/diagnostics14232718.
3
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?

本文引用的文献

1
Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.基于双示踪剂PET/CT对无功能胰腺神经内分泌肿瘤侵袭性的预测
EJNMMI Res. 2019 Dec 23;9(1):116. doi: 10.1186/s13550-019-0585-7.
2
Immunohistochemical Expression of Somatostatin Receptor Subtypes in a Panel of Neuroendocrine Neoplasias.免疫组化检测神经内分泌肿瘤中生长抑素受体亚型的表达。
J Histochem Cytochem. 2019 Oct;67(10):735-743. doi: 10.1369/0022155419856900. Epub 2019 Jun 10.
3
Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
中枢神经系统转移患者的靶向放射性核素治疗:被忽视的潜力?
Neuro Oncol. 2024 Dec 9;26(Supplement_9):S229-S241. doi: 10.1093/neuonc/noae192.
4
SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma.SSTR2 与 EGFR 呈正相关,可预测鼻咽癌的不良预后。
J Clin Pathol. 2024 Nov 19;77(12):829-834. doi: 10.1136/jcp-2023-208987.
5
Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs.PET/CT 检测分化良好的神经内分泌肿瘤肝转移的诊断性能。
Cancer Imaging. 2023 Apr 25;23(1):41. doi: 10.1186/s40644-023-00556-9.
6
Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61.使用新型兔单克隆抗人 SST4 抗体 7H49L61 重新评估支气管肺和胃肠胰神经内分泌肿瘤中的生长抑素受体 SST4 表达。
Sci Rep. 2022 Aug 30;12(1):14722. doi: 10.1038/s41598-022-19014-w.
生长抑素受体表达与肺类癌肿瘤的转移和患者预后相关。
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2083-2093. doi: 10.1210/jc.2018-01931.
4
Prognosis of patients with neuroendocrine tumor: a SEER database analysis.神经内分泌肿瘤患者的预后:一项监测、流行病学和最终结果(SEER)数据库分析
Cancer Manag Res. 2018 Nov 13;10:5629-5638. doi: 10.2147/CMAR.S174907. eCollection 2018.
5
The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.世界卫生组织胰腺神经内分泌肿瘤新分类。
Endocrinol Metab Clin North Am. 2018 Sep;47(3):463-470. doi: 10.1016/j.ecl.2018.04.008. Epub 2018 Jul 11.
6
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
7
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.双生长抑素受体/氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在转移性神经内分泌肿瘤中的应用:一种具有预后意义的新型分级方案的提议
Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017.
8
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.神经内分泌肿瘤护理标准的ENETS共识指南:小肠和胰腺神经内分泌肿瘤的手术治疗
Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25.
9
Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.68Ga-DOTATOC与18F-FDG联合正电子发射断层扫描/计算机断层扫描在胰腺神经内分泌肿瘤诊断检查中的作用:对手术决策管理的启示
Pancreas. 2017 Jan;46(1):42-47. doi: 10.1097/MPA.0000000000000745.
10
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.神经内分泌肿瘤中生长抑素受体表达与临床结局的关联
Pancreas. 2016 Nov;45(10):1386-1393. doi: 10.1097/MPA.0000000000000700.